Plant ribosome-inactivating proteins type II induce the unfolded protein response in human cancer cells

Smallshaw JE, Vitetta ES (2010) A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity. Vaccine 28:2428–2435 Ng TB, Wong JH, Wang H (2010) Recent progress in research on ribosome inactivating proteins. Curr Protein Pept Sci 11:37–53 Stirpe F, Battelli MG (2006) Ribosome-inactivating proteins: progress and problems. Cell Mol Life Sci 63:1850–1866 Herrera L, Bostrom B, Gore L, Sandler E, Lew G, Schlegel PG, Aquino V, Ghetie V, Vitetta ES, Schindler J (2009) A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia. J Pediatr Hematol Oncol 31:936–941 Voss C, Eyol E, Frank M, von der Lieth CW, Berger MR (2006) Identification and characterization of riproximin, a new type II ribosome-inactivating protein with antineoplastic activity from Ximenia americana. FASEB J 20:1194–1196 Voss C, Eyol E, Berger MR (2006) Identification of potent anticancer activity in Ximenia americana aqueous extracts used by African traditional medicine. Toxicol Appl Pharmacol 211:177–187 Voss C. Identifizierung und Charakterisierung des antineoplastischen Wirkstoffs Riproximin, ein neues Ribosomen-inaktivierendes Protein vom Typ 2 aus Ximenia americana. Dissertation Medizinische Fakultät, Ruprecht-Karls-Universität Heidelberg. 2005. Ref Type: Thesis/Dissertation Malhotra JD, Kaufman RJ (2007) The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol 18:716–731 Verfaillie T, Salazar M, Velasco G, Agostinis P (2010) Linking ER stress to autophagy: potential implications for cancer therapy. Int J Cell Biol 2010:930509 Kim I, Xu W, Reed JC (2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 7:1013–1030 Boyce M, Yuan J (2006) Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 13:363–373 Jiang HY, Wek SA, McGrath BC, Lu D, Hai T, Harding HP, Wang X, Ron D, Cavener DR, Wek RC (2004) Activating transcription factor 3 is integral to the eukaryotic initiation factor 2 kinase stress response. Mol Cell Biol 24:1365–1377 Ma Y, Brewer JW, Diehl JA, Hendershot LM (2002) Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. J Mol Biol 318:1351–1365 Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, Sakaguchi M, Takaoka M, Tanimoto R, Nasu Y, Huh NH, Kumon H (2008) Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res 68:8333–8341 Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881–891 Glimcher LH (2010) XBP1: the last two decades. Ann Rheum Dis 69(Suppl 1):i67–i71 Battelli MG, Musiani S, Buonamici L, Santi S, Riccio M, Maraldi NM, Girbes T, Stirpe F (2004) Interaction of volkensin with HeLa cells: binding, uptake, intracellular localization, degradation and exocytosis. Cell Mol Life Sci 61:1975–1984 Eberwine J, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R, Zettel M, Coleman P (1992) Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA 89:3010–3014 Melchior WB Jr, Tolleson WH (2010) A functional quantitative polymerase chain reaction assay for ricin, Shiga toxin, and related ribosome-inactivating proteins. Anal Biochem 396:204–211 Korcheva V, Wong J, Corless C, Iordanov M, Magun B (2005) Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome. Am J Pathol 166:323–339 Gupta P, Walter MR, Su ZZ, Lebedeva IV, Emdad L, Randolph A, Valerie K, Sarkar D, Fisher PB (2006) BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Cancer Res 66:8182–8191 Endo Y, Mitsui K, Motizuki M, Tsurugi K (1987) The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28S ribosomal RNA caused by the toxins. J Biol Chem 262:5908–5912 Olsnes S, Pihl A (1972) Ricin: a potent inhibitor of protein synthesis. FEBS Lett 20:327–329 Battelli MG (2004) Cytotoxicity and toxicity to animals and humans of ribosome-inactivating proteins. Mini Rev Med Chem 4:513–521 Colpoys WE, Cochran BH, Carducci TM, Thorpe CM (2005) Shiga toxins activate translational regulation pathways in intestinal epithelial cells. Cell Signal 17:891–899 Langer M, Mockel B, Eck J, Zinke H, Lentzen H (1999) Site-specific mutagenesis of mistletoe lectin: the role of RIP activity in apoptosis. Biochem Biophys Res Commun 264:944–948 Lee MS, Cherla RP, Leyva-Illades D, Tesh VL (2009) Bcl-2 regulates the onset of shiga toxin 1-induced apoptosis in THP-1 cells. Infect Immun 77:5233–5244 Shih SF, Wu YH, Hung CH, Yang HY, Lin JY (2001) Abrin triggers cell death by inactivating a thiol-specific antioxidant protein. J Biol Chem 276:21870–21877 Spooner RA, Smith DC, Easton AJ, Roberts LM, Lord JM (2006) Retrograde transport pathways utilised by viruses and protein toxins. Virol J 3:26 Parikh BA, Tortora A, Li XP, Tumer NE (2008) Ricin inhibits activation of the unfolded protein response by preventing splicing of the HAC1 mRNA. J Biol Chem 283:6145–6153 Schroder M (2008) Endoplasmic reticulum stress responses. Cell Mol Life Sci 65:862–894 Healy SJ, Gorman AM, Mousavi-Shafaei P, Gupta S, Samali A (2009) Targeting the endoplasmic reticulum-stress response as an anticancer strategy. Eur J Pharmacol 625:234–246